 BOCA RATON, Florida., Feb. 08, 2022 GLOBE NEWSWIRE -- INmune Bio, Inc. NASDAQ: INMB the Company, a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that Raymond J. Tesi, MD, President and CEO, will present at the BIO CEO Investor Conference being held February 14 17 at the Marriott Marquis in New York City. 